Intimate Brightening (TCA-Free)

652

Clinical procedure guide for TCA-free intimate area brightening — 12-agent system for ultra-sensitive perineo-vulvar zones

Depth
Very Superficial
Contact
~30 min
Neutralize
Self-neutralizing — no neutralization required
Fitzpatrick
I–VI
Sessions
6–8
Downtime
None — painless, zero downtime

Overview

Clinical procedure guide for TCA-free intimate area brightening — 12-agent system for ultra-sensitive perineo-vulvar zones

01

Safety

Critical
PATCH TEST IS 100% MANDATORY before every first session with a new patient. This product is formulated for ultra-sensitive intimate zones — even though it is TCA-free and gentle, individual sensitivity varies significantly. Never skip the patch test. Never apply to mucous membranes. Never apply to broken or inflamed skin.

Contraindications

  • Active infection, fungal or bacterial, in the treatment area
  • Open wounds, cuts, abrasions, or broken skin in the treatment zone
  • Pregnancy or lactation
  • Active Herpes Simplex Virus (HSV) — outbreak or prodromal symptoms
  • Recent waxing, laser hair removal, or depilation within 7 days
  • Active inflammatory skin condition (dermatitis, eczema, psoriasis) in treatment area
  • Known allergy or hypersensitivity to any of the 12 active ingredients
  • Recent use of topical retinoids on the intimate area within 72 hours
  • Post-surgical wounds or scars less than 3 months old in the treatment zone
  • Patients currently on isotretinoin or within 6 months of discontinuation
  • Active genital warts or condylomata in the treatment area

Remove Product Immediately If

  1. Burning or escalating pain (beyond mild warmth)
  2. Visible erythema that deepens or becomes intense
  3. Edema or swelling in the treatment area
  4. Urticaria, hives, or welts
  5. Patient reports intense itching or stinging
  6. Any sign of allergic reaction (rash spreading beyond treatment area)
  7. Patient distress or inability to tolerate the procedure

Stop the procedure and neutralize with cold water or sodium bicarbonate.

02

Composition

IngredientConcentrationRole
Kojic Acid (1%)Primary tyrosinase inhibitor — chelates copper cofactor required for melanin synthesis, directly suppressing pigment production at enzymatic level
Alpha Arbutin (0.5%)Secondary tyrosinase inhibitor — hydroquinone glucoside that competitively blocks tyrosinase without cytotoxicity to melanocytes
Lactic Acid (2%)Gentle AHA exfoliation with inherent humectant properties — loosens corneocyte cohesion while maintaining hydration in delicate tissue
Niacinamide (0.5%)Blocks melanosome transfer from melanocytes to surrounding keratinocytes, reducing visible pigment deposition
Glutathione (0.2%)Shifts melanogenesis from eumelanin (dark) to pheomelanin (light) — produces lighter pigment at the source
Retinol (0.1%)Accelerates epidermal turnover, promoting shedding of pigmented superficial layers and normalizing melanocyte activity
Ferulic Acid (0.1%)Potent antioxidant that stabilizes and enhances efficacy of other depigmenting agents while providing UV-damage repair
Resorcinol (0.3%)Antiseptic and depigmenting agent — inhibits tyrosinase and disrupts melanin granule formation
Hyaluronic Acid (0.5%)Deep hydration and tissue plumping — maintains moisture barrier integrity in ultra-sensitive mucosa-adjacent tissue
Bisabolol (0.1%)Chamomile-derived anti-inflammatory — soothes irritation and reduces post-treatment erythema in sensitive tissue
Aloe Vera (0.3%)Wound healing acceleration and anti-inflammatory support — maintains tissue integrity during treatment
Centella Asiatica (0.1%)Stimulates collagen synthesis and strengthens skin barrier — madecassoside and asiaticoside promote tissue repair
03

Indications

Fitzpatrick I–VI
  • Intimate Area Hyperpigmentation
  • Ultra-Sensitive Zones
  • TCA-Intolerant Patients
  • First-Time Intimate Peel
  • Inguinal Darkening
  • Underarm Hyperpigmentation
04

Procedure

  1. 01

    Patient Consultation & Consent

    10–15 min

    Review patient history thoroughly. Confirm no contraindications. Discuss expectations: this is a gradual brightening protocol, not an instant peel. Obtain written informed consent. Ensure complete privacy for the procedure.

    • MANDATORY: Document Fitzpatrick type, prior intimate treatments, hair removal history, and any sensitivity history. This step is non-negotiable.
  2. 02

    Patch Test (MANDATORY)

    15–20 min

    Apply a small amount of product to the inner aspect of the upper thigh, close to but NOT on the intimate area. Mark the test site. Observe for a minimum of 15 minutes for any adverse reaction: erythema, burning, itching, urticaria, or edema.

    • CRITICAL: Patch test is 100% mandatory for EVERY new patient, no exceptions. If ANY adverse reaction occurs — redness, burning, swelling, or hives — do NOT proceed. Reschedule only after reaction fully resolves. For patients with known sensitivity, extend observation to 20 minutes.
  3. 03

    Cleanse Treatment Area

    3–5 min

    Gently cleanse the treatment area with PREP.01 Pre-Peel Cleanser or a mild, fragrance-free, pH-balanced cleanser. Remove any deodorant, talcum, or residue. Pat dry with sterile gauze. Do not rub or irritate the area.

    • Use gentle, non-abrasive motions only. The tissue in this zone is delicate. Do NOT use alcohol-based or astringent cleansers.
  4. 04

    Apply prodermic 652

    5–7 min

    Using a soft fan brush or sterile cotton-tip applicator, apply a thin, even layer of product to the treatment area. Work methodically in one direction. Ensure uniform coverage without pooling. Avoid mucous membranes, open cuts, or freshly shaved/waxed areas.

    • Apply in a single thin layer. Do NOT double-coat or layer on thick. Avoid contact with mucous membranes at all times. Use a mirror or adequate lighting to ensure precision application.
  5. 05

    Monitor During Contact Time

    ~30 min

    Allow ~30 minutes of contact time. During this period, check in with the patient every 5–10 minutes. Ask about any sensation: mild warmth is acceptable, burning or pain is NOT. The product is designed to be painless — any discomfort beyond mild warmth requires immediate attention.

    • This is a self-neutralizing formulation — it does NOT require manual neutralization. However, if the patient reports burning, stinging, or escalating discomfort at any point, wipe off immediately with damp sterile gauze and cold water. Do NOT wait.
  6. 06

    Remove Product & Post-Care

    5–7 min

    After the contact time, gently remove the product using damp sterile gauze with lukewarm water. Wipe in one direction — do not rub. Pat the area dry. Apply REST.01 Post-Peel Moisturizer or a fragrance-free barrier cream. Provide written post-care instructions.

    • Patient must avoid: tight clothing on the area for 24 hours, sexual activity for 48 hours, waxing/laser/shaving for 7 days, swimming pools/hot tubs for 48 hours, and harsh soaps/exfoliants for 7 days. Next session: 14–21 days.
05

Post-procedure

Daily regimen
Day 0Treatment Day Barrier cream applied in-clinic. No tight clothing for 24 hours. No sexual activity for 48 hours. Clean, breathable cotton undergarments only.
Days 1–3Mild Sensitivity Phase Some warmth or mild sensitivity is normal. Apply fragrance-free moisturizer 2–3x daily. No exfoliants, no scrubbing, no waxing. Cotton undergarments.
Days 3–7Possible Light Flaking Very mild, superficial flaking may occur — this is normal. Do NOT pick or peel. Continue moisturizer. Avoid swimming pools, hot tubs, and saunas.
Days 7–14Recovery Complete Skin returns to normal. Resume regular routine. Avoid harsh exfoliants until next session. May resume waxing/shaving after Day 7.
Days 14–21Between Sessions Schedule next session. Continue gentle skincare. Apply brightening maintenance cream (VC.cr or DPG.cr) if prescribed by physician.
06

Session plan

Sessions
6–8
Interval
14–21 days
Downtime
None — painless, zero downtime
Total
3–6 months
Progressive dose schedule
SessionContact time
Sessions 1–225–30 min contact
Sessions 3–430 min contact
Sessions 5–630 min contact
Sessions 7–830 min contact (if needed)

After completing the initial program, 1 maintenance session every 2–3 months may be recommended to sustain results. Home-care with VC.cr (Vitamin C Cream) or DPG.cr (Depigmenting Cream) between sessions enhances and maintains results.